CoChat
Sign Up
Cited by 47

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

ULK2 is essential for degradation of ubiquitinated protein aggregates and homeostasis in skeletal muscle

Fuqua, Jordan D., Mere, Caleb P., Kronemberger, Ana, Blomme, Jay, Bae, Dam, Turner, Kristen D., Harris, Matthew P., Scudese, Estevão, Edwards, Mitchell, Ebert, Scott M., de Sousa, Luís G. O., Bodine, Sue C., Yang, Ling, Adams, Christopher M., Lira, Vitor A.·2019·The FASEB Journal
DOI 10.1096/fj.201900766rPMC PMC6902739
Open this paper in CoChat — free account

Abstract

Basal protein turnover, which largely relies on the degradation of ubiquitinated substrates, is instrumental for maintenance of muscle mass and function. However, the regulation of ubiquitinated protein degradation in healthy, nonatrophying skeletal muscle is still evolving, and potential tissue‐specific modulators remain unknown. Using an unbiased expression analysis of 34 putative autophagy genes across mouse tissues, we identified unc‐51 like autophagy activating kinase ( Ulk )2, a homolog of the yeast autophagy related protein 1, as particularly enriched in skeletal muscle. Subsequent experiments revealed accumulations of insoluble ubiquitinated protein aggregates associated with the adaptors sequestosome 1 (SQSTM1, also known as p62) and next to breast cancer type 1 susceptibility protein gene 1 protein (NBR1) in adult muscles with ULK2 deficiency. ULK2 deficiency also led to impaired muscle force and caused myofiber atrophy and degeneration. These features were not observed in muscles with deficiency of the ULK2 paralog, ULK1. Furthermore, short‐term ULK2 deficiency did not impair autophagy initiation, autophagosome to lysosome fusion, or protease activities of the lysosome and proteasome. Altogether, our results indicate that skeletal muscle ULK2 has a unique role in basal selective protein degradation by stimulating the recognition and proteolytic sequestration of insoluble ubiquitinated protein aggregates associated with p62 and NBR1. These findings have potential implications for conditions of poor protein homeostasis in muscles as observed in several myopathies and aging.—Fuqua, J. D., Mere, C. P., Kronemberger, A., Blomme, J., Bae, D., Turner, K. D., Harris, M. P., Scudese, E., Edwards, M., Ebert, S. M., de Sousa, L. G. O., Bodine, S. C., Yang, L., Adams, C. M., Lira, V. A. ULK2 is essential for degradation of ubiquitinated protein aggregates and homeostasis in skeletal muscle. FASEB J. 33, 11735‐11745 (2019). www.fasebj.org

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1096/fj.201900766r

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Ulk2 is enriched in skeletal muscle. BioGPS data set: Gene Atlas MOE430, gcrma (30) was used for A, B, D. A) Skeletal muscle expression of 34 putative autophagy genes expressed as fold change over median expression across multiple mouse tissues and cell lines. B) Mean correlation between skeletal muscle–specific genes and Ulk2. C) mRNA copy number of Ulk2 and Ulk1 in plantaris skeletal muscle of mice with normal food access (n = 9). D) DAVID functional annotation clustering analysis showing the top 10 Gene Ontology (GO) categories of genes with the highest expression correlation with Ulk2 across tissues (r ≥ 0.8; r2 ≥ 0.64). Actn3, actinin 3; Casq1, calsequestrin 1; Myoz1, myozenin 1. Data are means ± sem. ****P < 0.0001.
Figure 1 Ulk2 is enriched in skeletal muscle. BioGPS data set: Gene Atlas MOE430, gcrma (30) was used for A, B, D. A) Skeletal muscle expression of 34 putative autophagy genes expressed as fold change over median expression across multiple mouse tissues and cell lines. B) Mean correlation between skeletal muscle–specific genes and Ulk2. C) mRNA copy number of Ulk2 and Ulk1 in plantaris skeletal muscle of mice with normal food access (n = 9). D) DAVID functional annotation clustering analysis showing the top 10 Gene Ontology (GO) categories of genes with the highest expression correlation with Ulk2 across tissues (r ≥ 0.8; r2 ≥ 0.64). Actn3, actinin 3; Casq1, calsequestrin 1; Myoz1, myozenin 1. Data are means ± sem. ****P < 0.0001.CC BY · PubMed Central
Figure 2 ULK2 and ULK1 are dispensable for starvation-induced atrophy in skeletal muscle. Data were obtained from control and ULK-deficient TA muscles 1 wk after electroporation. A) Relative Ulk2 mRNA in control and ULK2-deficient muscles (n = 5). B) Relative Ulk1 mRNA in control and ULK1-deficient muscle (n = 4). C, D) Percent change in body mass after 48 h of starvation in electroporated mice (n = 6–9). E) Representative images of transfected fibers (GFP) in control and ULK2-deficient muscles. F) Representative images of transfected fibers (GFP) in control and ULK1-deficient muscles. G) Quantification of mean fiber diameter of control and ULK2-deficient muscles in mice with normal food access or after 48 h of starvation (n = 6–9). H) Quantification of mean fiber diameter of control and ULK1-deficient muscles in mice with normal food access or after 48 h of starvation (n = 7–8). Data are means ± sem. *P < 0.05, **P < 0.01,****P < 0.0001.
Figure 2 ULK2 and ULK1 are dispensable for starvation-induced atrophy in skeletal muscle. Data were obtained from control and ULK-deficient TA muscles 1 wk after electroporation. A) Relative Ulk2 mRNA in control and ULK2-deficient muscles (n = 5). B) Relative Ulk1 mRNA in control and ULK1-deficient muscle (n = 4). C, D) Percent change in body mass after 48 h of starvation in electroporated mice (n = 6–9). E) Representative images of transfected fibers (GFP) in control and ULK2-deficient muscles. F) Representative images of transfected fibers (GFP) in control and ULK1-deficient muscles. G) Quantification of mean fiber diameter of control and ULK2-deficient muscles in mice with normal food access or after 48 h of starvation (n = 6–9). H) Quantification of mean fiber diameter of control and ULK1-deficient muscles in mice with normal food access or after 48 h of starvation (n = 7–8). Data are means ± sem. *P < 0.05, **P < 0.01,****P < 0.0001.CC BY · PubMed Central
Figure 3 Accumulation of ubiquitinated proteins and autophagy adaptors occur early in ULK2-deficient muscles. Data were obtained from control and ULK-deficient TA muscles 1 wk after electroporation. A) Representative immunoblots of LC3 (LC3A/B), adaptor proteins, and ubiquitinated proteins in control and ULK2-deficient muscles of mice with normal food access or after 24 h of starvation. B) Quantification of LC3, adaptor proteins, and ubiquitinated proteins (n = 5–8). C) mRNA levels of genes encoding Lc3a and Lc3b (Map1lc3a and Map1lcb, respectively), adaptor proteins p62 (Sqstm1) and Nbr1, and ubiquitin [ubiquitin b (Ubb) and unibquitin c (Ubc)] in control and ULK2-deficient muscles of mice with normal food access (left) and after 24-h starvation (right) (n = 5). D) Representative immunoblots of LC3 (LC3A/B), adaptor proteins, and ubiquitinated proteins in control and ULK1-deficient muscles of mice with normal food access or after 24 h of starvation. E) Quantification of LC3, adaptor proteins, and ubiquitinated proteins (n = 6–8). F) mRNA levels of the genes indicated in C in control and ULK1-deficient muscles of mice with normal food access (left) and after 24 h of starvation (right) (n = 4). UB, ubiquitin. Data are means ± sem. *P < 0.05.
Figure 3 Accumulation of ubiquitinated proteins and autophagy adaptors occur early in ULK2-deficient muscles. Data were obtained from control and ULK-deficient TA muscles 1 wk after electroporation. A) Representative immunoblots of LC3 (LC3A/B), adaptor proteins, and ubiquitinated proteins in control and ULK2-deficient muscles of mice with normal food access or after 24 h of starvation. B) Quantification of LC3, adaptor proteins, and ubiquitinated proteins (n = 5–8). C) mRNA levels of genes encoding Lc3a and Lc3b (Map1lc3a and Map1lcb, respectively), adaptor proteins p62 (Sqstm1) and Nbr1, and ubiquitin [ubiquitin b (Ubb) and unibquitin c (Ubc)] in control and ULK2-deficient muscles of mice with normal food access (left) and after 24-h starvation (right) (n = 5). D) Representative immunoblots of LC3 (LC3A/B), adaptor proteins, and ubiquitinated proteins in control and ULK1-deficient muscles of mice with normal food access or after 24 h of starvation. E) Quantification of LC3, adaptor proteins, and ubiquitinated proteins (n = 6–8). F) mRNA levels of the genes indicated in C in control and ULK1-deficient muscles of mice with normal food access (left) and after 24 h of starvation (right) (n = 4). UB, ubiquitin. Data are means ± sem. *P < 0.05.CC BY · PubMed Central
Figure 4 ULK2 deficiency causes deposition of insoluble ubiquitinated protein aggregates without impairing autophagy or the proteasome. Data were obtained from control and ULK-deficient TA muscles 1 wk after electroporation. A) Representative immunoblots of LC3-I and LC3-II in vehicle (−)– or colchicine (+)–treated control and ULK2-deficient muscles. B) Quantification of LC3-II/LC3-I immunoblot (n = 5). C) Representative immunoblots of CTSB, LAMP1, and 20S proteasomal subunit proteins in control and ULK2-deficient muscles. D) Quantification of CTSB, LAMP1, and 20S in control and ULK2-deficient muscle (n = 5–7). E) CTSB activity (left) and chymotrypsin activity (ATP-independent [20S] and ATP-dependent [26S]) (right) in control and ULK2-deficient muscles (n = 6). F) Representative Coomassie Blue stain of pellet and supernatant fractions of control and ULK2-deficient muscles. G) Representative immunoblots of adaptor and ubiquitinated proteins in the pellet and supernatant fractions of control and ULK2-deficient muscles. H) Quantification of adaptor and ubiquitinated proteins in the pellet and supernatant fractions (n = 7). UB, ubiquitin. Data are means ± sem. *P < 0.05, **P < 0.01.
Figure 4 ULK2 deficiency causes deposition of insoluble ubiquitinated protein aggregates without impairing autophagy or the proteasome. Data were obtained from control and ULK-deficient TA muscles 1 wk after electroporation. A) Representative immunoblots of LC3-I and LC3-II in vehicle (−)– or colchicine (+)–treated control and ULK2-deficient muscles. B) Quantification of LC3-II/LC3-I immunoblot (n = 5). C) Representative immunoblots of CTSB, LAMP1, and 20S proteasomal subunit proteins in control and ULK2-deficient muscles. D) Quantification of CTSB, LAMP1, and 20S in control and ULK2-deficient muscle (n = 5–7). E) CTSB activity (left) and chymotrypsin activity (ATP-independent [20S] and ATP-dependent [26S]) (right) in control and ULK2-deficient muscles (n = 6). F) Representative Coomassie Blue stain of pellet and supernatant fractions of control and ULK2-deficient muscles. G) Representative immunoblots of adaptor and ubiquitinated proteins in the pellet and supernatant fractions of control and ULK2-deficient muscles. H) Quantification of adaptor and ubiquitinated proteins in the pellet and supernatant fractions (n = 7). UB, ubiquitin. Data are means ± sem. *P < 0.05, **P < 0.01.CC BY · PubMed Central
Figure 5 ULK2 is required for maintenance of skeletal muscle force, mass, and integrity. Data were obtained from control and ULK-deficient TA muscles 4 wk after electroporation. A) Relative Ulk2 mRNA in control and ULK2-deficient muscles (n = 5–6). B) Weekly monitoring of maximal isometric torque in ankle dorsiflexors in mice with unilateral TA deficiency of ULK2 (n = 5). C) Wet muscle mass normalized to body mass in control and ULK2-deficient muscles (n = 5). D) Mean muscle fiber diameter as previously indicated in C (n = 6). E) Relative Ulk1 mRNA in control and ULK1-deficient muscles (n = 5–6). F) Weekly monitoring of maximal isometric torque in ankle dorsiflexors in mice with unilateral TA deficiency of ULK1 (n = 6). G) Wet muscle mass normalized to body mass in control and ULK1-deficient muscles (n = 6). H) Mean muscle fiber diameter as previously indicated in G (n = 6). I) Representative images of myofibers following immunofluorescence staining for dystrophin and GFP in control and either ULK2- or ULK1-deficient muscles. J) Representative H&E images denoting centrally nucleated fibers in ULK2-deficient muscle. K) Quantification of centrally nucleated fibers in control and ULK2-deficient muscles (n = 6). L) Quantification of centrally nucleated fibers in control and ULK1-deficient muscles (n = 6). M) Representative H&E images of an entire cross section of ULK2-deficient muscle depicting areas of myofiber degeneration and regeneration (black arrow heads, left) and an enlarged area denoting several abnormally small, centrally nucleated, degenerating fibers surrounded by infiltrating cells (black arrows, right). Data are means ± sem. *P < 0.05, **P < 0.01, ***P < 0.001.
Figure 5 ULK2 is required for maintenance of skeletal muscle force, mass, and integrity. Data were obtained from control and ULK-deficient TA muscles 4 wk after electroporation. A) Relative Ulk2 mRNA in control and ULK2-deficient muscles (n = 5–6). B) Weekly monitoring of maximal isometric torque in ankle dorsiflexors in mice with unilateral TA deficiency of ULK2 (n = 5). C) Wet muscle mass normalized to body mass in control and ULK2-deficient muscles (n = 5). D) Mean muscle fiber diameter as previously indicated in C (n = 6). E) Relative Ulk1 mRNA in control and ULK1-deficient muscles (n = 5–6). F) Weekly monitoring of maximal isometric torque in ankle dorsiflexors in mice with unilateral TA deficiency of ULK1 (n = 6). G) Wet muscle mass normalized to body mass in control and ULK1-deficient muscles (n = 6). H) Mean muscle fiber diameter as previously indicated in G (n = 6). I) Representative images of myofibers following immunofluorescence staining for dystrophin and GFP in control and either ULK2- or ULK1-deficient muscles. J) Representative H&E images denoting centrally nucleated fibers in ULK2-deficient muscle. K) Quantification of centrally nucleated fibers in control and ULK2-deficient muscles (n = 6). L) Quantification of centrally nucleated fibers in control and ULK1-deficient muscles (n = 6). M) Representative H&E images of an entire cross section of ULK2-deficient muscle depicting areas of myofiber degeneration and regeneration (black arrow heads, left) and an enlarged area denoting several abnormally small, centrally nucleated, degenerating fibers surrounded by infiltrating cells (black arrows, right). Data are means ± sem. *P < 0.05, **P < 0.01, ***P < 0.001.CC BY · PubMed Central
Figure 6 ULK2 is essential for skeletal muscle homeostasis. Our studies reveal that the Ulk2 gene presents a skeletal muscle–enriched pattern of expression in mice and that its deficiency in skeletal muscle, despite not impairing autophagy flux and proteolytic activities of the lysosome and proteasome, leads to robust accumulation of insoluble ubiquitinated protein aggregates associated with the adaptors p62 and NBR1. These findings suggest a key role for ULK2 in modulating the recognition and sequestration of ubiquitinated protein aggregates for degradation by autophagy (and potentially by the proteasome). The ensuing inability of ULK2-deficient muscle fibers to clear proteotoxic aggregates leads to atrophy, impaired force production, myofiber degeneration, and a generally unhealthy morphology of the muscle. Of note, these cellular events and functional outcomes are not observed in ULK1-deficient muscle. Autophagy is depicted with a phagophore and an autophagosome (white) and lysosome (blue).
Figure 6 ULK2 is essential for skeletal muscle homeostasis. Our studies reveal that the Ulk2 gene presents a skeletal muscle–enriched pattern of expression in mice and that its deficiency in skeletal muscle, despite not impairing autophagy flux and proteolytic activities of the lysosome and proteasome, leads to robust accumulation of insoluble ubiquitinated protein aggregates associated with the adaptors p62 and NBR1. These findings suggest a key role for ULK2 in modulating the recognition and sequestration of ubiquitinated protein aggregates for degradation by autophagy (and potentially by the proteasome). The ensuing inability of ULK2-deficient muscle fibers to clear proteotoxic aggregates leads to atrophy, impaired force production, myofiber degeneration, and a generally unhealthy morphology of the muscle. Of note, these cellular events and functional outcomes are not observed in ULK1-deficient muscle. Autophagy is depicted with a phagophore and an autophagosome (white) and lysosome (blue).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 38

  1. 10.5455/aim.2014.22.406-410 · DOI
  2. 10.1301/nr.2003.may.157-167 · DOI
  3. 10.1097/01241398-200001000-00016 · DOI
  4. 10.2337/diab.30.12.1000 · DOI · Paper page
  5. 10.1056/NEJM199612193352507 · DOI
  6. 10.1126/science.aac4354 · DOI
  7. 10.1016/j.cmet.2008.09.002 · DOI · Paper page
  8. 10.1085/jgp.201611603 · DOI
  9. 10.1038/35022604 · DOI · Paper page
  10. 10.1038/nm.2247 · DOI · Paper page
  11. 10.18632/aging.101141 · DOI
  12. 10.1073/pnas.95.21.12100 · DOI
  13. 10.1073/pnas.162172899 · DOI
  14. 10.1074/jbc.273.39.25216 · DOI
  15. 10.1681/ASN.2006010083 · DOI · Paper page
  16. 10.1016/j.cell.2010.01.028 · DOI · Paper page
  17. 10.1152/physrev.00030.2009 · DOI
  18. 10.1016/j.ceb.2009.11.014 · DOI · Paper page
  19. 10.1186/1745-7580-4-5 · DOI
  20. 10.1038/nprot.2008.211 · DOI · Paper page
  21. 10.1093/nar/gkn923 · DOI · Paper page
  22. 10.4161/auto.6.7.12785 · DOI · Paper page
  23. 10.1016/j.ymeth.2014.12.019 · DOI
  24. 10.1371/journal.pone.0119382 · DOI
  25. 10.1172/JCI86522 · DOI
  26. 10.1152/ajpendo.00380.2013 · DOI
  27. 10.1152/ajpcell.00104.2009 · DOI · Paper page
  28. 10.1074/jbc.M703663200 · DOI · Paper page
  29. 10.1016/j.molcel.2011.06.018 · DOI · Paper page
  30. 10.1080/15548627.2016.1140293 · DOI · Paper page
  31. 10.1093/hmg/8.5.813 · DOI
  32. 10.1038/s41598-017-08480-2 · DOI
  33. 10.1128/MCB.24.18.8055-8068.2004 · DOI
  34. 10.1074/jbc.M114.567032 · DOI · Paper page
  35. 10.4161/auto.26563 · DOI · Paper page
  36. 10.1128/MCB.01082-08 · DOI · Paper page
  37. 10.1016/j.molcel.2011.07.039 · DOI
  38. 10.1371/journal.pgen.1004987 · DOI

Cited by

Sorted by citations

See all 47

Metadata

Authors
Fuqua, J. D., Mere, C. P., Kronemberger, A., Blomme, J., Bae, D., Turner, K. D., Harris, M. P., Scudese, E., Edwards, M., Ebert, S. M., de Sousa, L. G. O., Bodine, S. C., Yang, L., Adams, C. M., & Lira, V. A.
Venue
The FASEB Journal
Publisher
Wiley
Published
2019-08-09
Volume
33
Issue
11
Pages
11735-12745
ISSN
  • 0892-6638
  • 1530-6860
DOI
10.1096/fj.201900766r
PMC
PMC6902739
Cited by
47
References
16
Language
en
Licence
creativecommons.org/licenses/by-nc-nd/2.0/) (vor)
Funders
American Heart Association (16SDG30360001)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review